Advancing Protein Sequencing with Single-Particle Mass Spectrometry
Conventional proteomics often leaves gaps in sequencing coverage and fails to fully resolve complex proteins, limiting actionable insight. ImmPro’s ProteoSight™ platform addresses these challenges with a novel single-particle mass spectrometry approach, enabling precise, comprehensive, and genome-independent protein sequencing.
The platform combines targeted isolation with high-resolution fragmentation, delivering unprecedented accuracy in mapping post-translational modifications and uncovering previously undetectable variants. Benchmark studies highlight ProteoSight’s ability to achieve exceptional coverage and sequence continuity, even on large, complex proteins.
This white paper outlines the ProteoSight™ workflow, performance benchmarks, and its potential to transform biomarker discovery, therapeutic development, and clinical diagnostics.
Download the full white paper to learn how ProteoSight™ can enhance your research.
*Access requires name, instituion, and email